Yahoo Web Search

Search results

1. • 

     Syrian first lady Asma Assad diagnosed with leukemia, president's office says

     Associated Press via Yahoo News· 3 days ago

     Syrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad...

2. • Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

     The Yuma Sun· 14 hours ago

     The ASCO Annual Meeting is being held online and in person in Chicago, Illinois from May 31 to June 4, 2024. The EHA2024 Congress is being held online and in person in Madrid, Spain from June 13 to June 16, 2024.

3. • Recommendations from the AML molecular MRD expert advisory board - Leukemia

     Nature· 1 day ago

     The standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of targeted therapies ...

4. • Syrian first lady diagnosed with leukemia

     China Daily· 3 days ago

     Syrian First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia, a type of blood cancer, the Syrian presidency said in ...

5. • 

     St. Jude patient's lifesaving story: 'I was losing my ability to function at that point'

     ABC 13 Lynchburg· 2 days ago

     Doctors diagnosed Anna with acute myeloid leukemia, an aggressive form of the disease, when she was...

6. • 

     In the news | Arkansas Democrat Gazette

     Arkansas Democrat-Gazette· 2 days ago

     Asma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow ...

7. • ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...

     CBS 47 Fresno· 10 hours ago

     Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...

8. • Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia

     Nature· 2 days ago

     Myelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased risk of progression to

9. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 18 hours ago

     The drug is at the center of Novartis’ pending $2.9 billion acquisition of MorphoSys, but there are questions about its safety after a Stat report...

10. • MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com

      ETF DAILY NEWS· 6 hours ago

      StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...